Literature DB >> 16264329

Tackling the heterogeneity of CVID.

Sigune Goldacker1, Klaus Warnatz.   

Abstract

PURPOSE OF REVIEW: Common variable immunodeficiency is clinically the most relevant primary immunodeficiency of the adult. Its heterogeneity has hindered progress in the pathogenetic understanding of the majority of common variable immunodeficiency patients. This abstract summarizes recent aspects of the field and emphasizes the need for a commonly accepted approach to classify common variable immunodeficiency. RECENT
FINDINGS: In the last 2 years, the first genetic defects underlying common variable immunodeficiency, including ICOS, TACI, BAFF-R and CD19, have been identified. The analysis of dendritic cells demonstrated alterations in a majority of patients in addition to the disturbed T and B-cell function. Several changes of the adaptive immune system might be secondary to an underlying chronic inflammatory setting possibly due to a HHV8 infection in a subgroup of patients with granulomatous disease, autoimmune phenomena and T-cell dysfunction. The occurrence of granulomatous inflammation is associated with a worse prognosis compared with common variable immunodeficiency patients without granuloma.
SUMMARY: The pathogenesis of common variable immunodeficiency includes disturbances of the adaptive as well as innate immune system. Identified monogenic defects account for about 10% of cases, leaving the majority of defects undefined and certainly in part epigenetic. To combine the known aspects of the pathogenesis of common variable immunodeficiency to a conclusive picture, the clinical and immunologic phenotyping of patients needs to be standardized.

Entities:  

Mesh:

Year:  2005        PMID: 16264329     DOI: 10.1097/01.all.0000191888.97397.b3

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  22 in total

1.  [Inflammatory reactions of the spleen].

Authors:  T Rüdiger; M Hartmann; H K Müller-Hermelink; A Marx
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

Review 2.  Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

3.  Thymic and bone marrow output in patients with common variable immunodeficiency.

Authors:  Federico Serana; Paolo Airò; Marco Chiarini; Cinzia Zanotti; Mirko Scarsi; Micol Frassi; Vassilios Lougaris; Alessandro Plebani; Luigi Caimi; Luisa Imberti
Journal:  J Clin Immunol       Date:  2011-04-14       Impact factor: 8.317

4.  Mutational analysis of human BLyS in patients with common variable immunodeficiency.

Authors:  Claretta Gioia Losi; Ulrich Salzer; Roberta Gatta; Vassilios Lougaris; Gemma Cattaneo; Antonella Meini; Annarosa Soresina; Bodo Grimbacher; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2006-06-01       Impact factor: 8.317

5.  Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.

Authors:  Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony S Fauci
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

6.  TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.

Authors:  Monica Martinez-Gallo; Lin Radigan; María Belén Almejún; Natalia Martínez-Pomar; Núria Matamoros; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2012-12-11       Impact factor: 10.793

7.  Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.

Authors:  Li Zhang; Lin Radigan; Ulrich Salzer; Timothy W Behrens; Bodo Grimbacher; George Diaz; James Bussel; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

8.  TACI mutations and disease susceptibility in patients with common variable immunodeficiency.

Authors:  A E J Poodt; G J A Driessen; A de Klein; J J M van Dongen; M van der Burg; E de Vries
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

Review 9.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

10.  Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency.

Authors:  Nima Rezaei; Asghar Aghamohammadi; Seyed Davar Siadat; Mostafa Moin; Zahra Pourpak; Mehdi Nejati; Hojat Ahmadi; Samineh Kamali; Dariush Norouzian; Bahman Tabaraei; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2008-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.